MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Non-motor Scales"

  • 2019 International Congress

    Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

    N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)

    Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
  • 2019 International Congress

    Comparison between the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and the Non-Motor Symptoms Scale (NMSS)

    A. Schrag, A. Rizos, C. Rodriguez-Blazquez, D. Weintraub, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)

    Objective: To compare the performance of the Movement Disorders Society – Non-Motor Rating Scale (MDS-NMS) and its predecessor, the Non-Motor Symptoms Scale (NMSS). Background: The…
  • 2019 International Congress

    Long term evolution of ventilatory function in Parkinson’s disease

    G. Baille, C. Chenivesse, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)

    Objective: To assess the evolution of lung volumes and respiratory muscle strength after a 5 years follow-up in a cohort of patients with Parkinson’s disease…
  • 2019 International Congress

    Non-motor symptoms in Parkinson disease motor subtypes: a study using the new MDS-NMS

    P. Martinez-Martin, C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri (Madrid, Spain)

    Objective: To analyze the prevalence and severity of non-motor symptoms (NMS) in Parkinson disease (PD) motor subtypes (tremor-dominant, TD; postural instability/gait disorder, PIGD; and indeterminate),…
  • 2019 International Congress

    Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

    A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)

    Objective: To align with regulators on the utility and development strategy of novel clinical outcome assessments for use in Huntington’s disease (HD) clinical trials. Background:…
  • 2019 International Congress

    Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

    V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)

    Objective: Evaluate the association between drooling and striatal dopamine terminals. Test the assumption that drooling correlates with disease progression in de novo Parkinson’s disease (PD)…
  • 2019 International Congress

    The influence of physical activities on cognition in small group of Parkinson’s Disease patients

    J. Silva, M. Pereira, L. Piovesara, P. Azevedo, F. Cendes, A. D'Abreu, R. Guimarães (Campinas, Brazil)

    Objective: To assess the relation between cognitive performance and physical exercise in Parkinson's Disease patient. Background: Cognitive deficit is a common non-motor symptom in PD,…
  • 2019 International Congress

    Non motor fluctuations in Parkinson’s disease: Findings from a Tunisian cohort

    M. Ben Djebara, K. Laabidi, A. Nasri, A. Rekik, S. Mrabet, A. Gargouri, I. Kacem, R. Gouider (Tunis, Tunisia)

    Objective: To evaluate the frequency of non motor fluctuations (NMF) in Parkinson's disease (PD), their correlation with motor complications and their impact on the quality…
  • 2019 International Congress

    Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study

    JY. Lee, H. Ju, K. Im, MY. Ahn, KY. Kwon (Seoul, Republic of Korea)

    Objective: We aimed to investigate associations of striatal dopamine uptake and various non-motor symptoms in non-demented patients with Parkinson’s disease (PD). Background: Dopamine transporter (DAT)…
  • 2019 International Congress

    Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

    J. Rocha, E. Tolosa, J. Ferreira, A. Lees, O. Rascol, W. Poewe, A. Santos, D. Magalhães, P. Soares-da-Silva (Coronado, Portugal)

    Objective: To evaluate the impact of opicapone (OPC) on PDQ-39 in levodopa-treated Parkinson’s Disease (PD) patients with ‘early’ motor fluctuations. Background: OPC, a once-daily COMT…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 63
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley